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Background and aims: Hypertriglyceridaemia is both a primary cause of acute pancreatitis and an
epiphenomenon. This study aimed to define the associations between hypertriglyceridaemia and clinical
outcomes in patients admitted with acute pancreatitis.
Methods: This single-centre prospective observational study included patients with a confirmed clinical,
biochemical or radiological diagnosis of acute pancreatitis from August 2017 to September 2018. Baseline
demographics, aetiology of pancreatitis, and fasting triglyceride concentrations were recorded and
assessed against the surrogate markers of severity: admission to critical care, length of stay (LOS),
readmission to hospital, and mortality.
Results: In total, 304 patients with a mean ± SD age of 56.1 ± 19.7 years met the inclusion criteria. There
were 217 (71.4%) patients with normotriglyceridaemia (<150 mg/dL or <1.7 mmol/L), 47 (15.5%) with
mild hypertriglyceridaemia (150e199 mg/dL or 1.7e2.25 mmol/L) and 40 (13.2%) with moderate-to-
severe hypertriglyceridaemia (200 mg/dL or >2.25 mmol/L). The underlying aetiologies of acute
pancreatitis were gallstones (55%), alcohol (18%), idiopathic (15%), hypertriglyceridaemia (9%), iatrogenic
(2%) and bile duct abnormalities (1%). Patients with hypertriglyceridaemia were younger than those with
normotriglyceridaemia (p < 0.05). On multivariate regression, moderate-to-severe hypertriglyceridaemia
(OR 5.66, 95% CI: 1.87 to 17.19, p ¼ 0.002) and an elevated C-reactive protein concentration 120 mg/L
(OR 1.00, 95% CI: 1.00e1.01, p ¼ 0.040) were associated with admission to critical care. Moderate-to-
severe hypertriglyceridaemia was also associated with an increased LOS (p ¼ 0.002) but not read-
mission (p ¼ 0.752) or mortality (p ¼ 0.069).
Conclusion: Moderate-to-severe hypertriglyceridaemia in all aetiological causes of acute pancreatitis was
predictive of admission to critical care and prolonged LOS but not readmission or mortality.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and
Metabolism. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
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1. Introduction
Acute pancreatitis is a common presentation in hospitals
worldwide, with an incidence of 70 cases per 100,000 population
per annum [1]. It involves sudden inflammation of the pancreas
and can lead to local and systemic complications. While gallstones
and alcohol are the most common causes of acute pancreatitis,
hypertriglyceridaemia is reportedly the third commonest cause [2].
Hypertriglyceridaemia is defined as serum triglyceridefor Clinical Nutrition and Metabolism. This is an open access article under the CC BY
A. Adiamah et al. / Clinical Nutrition ESPEN 39 (2020) 227e233228concentration of more than 150mg/dL or 1.7 mmol/L and is present
in 31% of the adult population in the United States [3]. Severe
hypertriglyceridaemia refers to serum concentrations 1000 mg/
dL (11.3mmol/L) and 15e20% of patients identified as having severe
hypertriglyceridaemia develop acute pancreatitis [2].
Some studies have reported that regardless of the underlying
primary aetiology of acute pancreatitis, concurrent hyper-
triglyceridaemia is associated with greater severity, more frequent
development of persistent organ failure and poorer outcomes [4].
Others have suggested that hypertriglyceridaemia is associated
with aggravation of acute pancreatitis, increased local and systemic
complications, and increased admission to ICU [5,6]. A single centre
study of 50 patients with severe hypertriglyceridaemia and acute
pancreatitis described a mortality of 15% in such patients [7]. Deng
et al. found that on univariate analysis of patients with severe acute
pancreatitis, thosewith hypertriglyceridaemia had a significant risk
of mortality (13.1%) compared with patients with normotriglycer-
idaemia [8].
The exact pathophysiological mechanism of hyper-
triglyceridaemia in triggering and or exacerbating acute pancrea-
titis is still debatable. The most widely considered theory proposed
by Havel [9] suggests that occlusion of pancreatic capillaries by
chylomicrons leads to local hydrolysis of these triglyceride-rich li-
poproteins and release of high local concentrations of free fatty
acids. These aggregate into micelles with detergent properties that
injure the vascular endothelium and acinar cells of the pancreas.
The ensuing ischaemia creates an acidic environment, which trig-
gers further free fatty acid toxicity. The cyclical micelle-free fatty
acid production and the potential to induce ischaemia and necrosis
may, in part, contribute to the suggested severity associated with
hypertriglyceridaemia in the context of pancreatitis [9,10]. Other
mechanisms suggested include a genetic predisposition and
metabolic abnormalities including insulin resistance.
This study aimed to define, using a prospective cohort, the as-
sociations between hypertriglyceridaemia and clinical outcomes in
patients admitted with acute pancreatitis.2. Methods
2.1. Study population
Consecutive patients diagnosed with acute pancreatitis from
August 2017 to September 2018 at Nottingham University Hospitals
NHS Trust, Queen's Medical Centre in the United Kingdom were
included in this prospective study. Acute pancreatitis was diag-
nosed based on clinical features, biochemistry or imaging: acute
onset epigastric pain often radiating to the back and elevated serum
lipase concentrations 3 times the upper limit of normal, and/or
evidence of acute pancreatitis on imaging. The studywas registered
with and approved by the hospital audit department (Approval no.
17-199c). The need to obtain consent from patients was waived.2.2. Definition and classification of hypertriglyceridaemia
In this study, hypertriglyceridaemia was defined based on
guidelines by the American Heart Association, National Lipid As-
sociation and The Endocrine Society [3,11,12]. Any patient with
serum triglyceride concentrations of 150 mg/dL or 1.7 mmol/L
was classified to have hypertriglyceridaemia. Furthermore, hyper-
triglyceridaemic patients were subcategorised into mild hyper-
triglyceridaemia (150e199 mg/dL or 1.7e2.25 mmol/L) andmoderate-to-severe hypertriglyceridaemia (200 mg/dL or
>2.25 mmol/L) [11].
2.3. Definition of primary aetiology
The primary aetiology of acute pancreatitis was determined
based on definitions summarised in Table 1. Gallstone pancreatitis
was diagnosedwhen gallstones were detected on ultrasound. Acute
pancreatitis secondary to alcohol excess was diagnosed if patients
met the criteria for alcohol excess on admission, namely drinking
35 units a week or more for women, and 50 units a week or more
for men [13].
Hypertriglyceridaemia was diagnosed as the primary aetiology
of acute pancreatitis if patients had mild or moderate hyper-
triglyceridaemia in the absence of other causes. However, if a
patient had severe hypertriglyceridaemia, this was the primary
cause of acute pancreatitis regardless of the presence of other
potential aetiologies. There is currently a lack of minimum
diagnostic triglyceride concentration for hypertriglyceridaemia
associated acute pancreatitis [14]. Iatrogenic acute pancreatitis
was diagnosed if acute pancreatitis was caused by a procedure
such as endoscopic retrograde cholangiopancreatography (ERCP).
Acute pancreatitis was thought to have been caused by abnormal
biliary structure in the presence of bile duct malignancy. Lastly, in
absence of all causes mentioned above, acute pancreatitis was
categorised as idiopathic.
2.4. Data collection
Data were collected using the hospital electronic clinical data-
bases and patient digital health record. Baseline demographic data
such as age, gender, body mass index and smoking status were
recorded. The underlying aetiology was determined based on
alcohol history, presence of gallstones on ultrasound and fasting
serum triglyceride concentrations collected within 24 h of
admission.
Other clinical and biochemical parameters collected included
the Acute Physiology and Chronic Health Evaluation II (APACHE II)
score, white cell count, and serum C-reactive protein (CRP), lipase
and bilirubin concentrations. Blood samples for fasting triglyceride
concentrations were taken on the morning after index admission.
The outcome measures of interest were admission to critical care
[intensive care unit (ICU) or high dependency unit (HDU)] e as a
clinical measure of severity of presentation, length of stay (LOS),
readmission to hospital and 30-day mortality. Based on the UK
guidelines for the management of acute pancreatitis CRP 120 mg/
L and APACHE II score 9 were prognosticators of severe acute
pancreatitis [15].
2.4. Statistical methods
Data were analysed using STATA/SE 15 software (StataCorp LLC,
College Station, TX, USA). Continuous variables were expressed as
mean and standard deviation or median (interquartile range),
while categorical variables were represented as percentages. De-
mographic data of the normotriglyceridaemia and hyper-
triglyceridaemia groups were analysed using the independent
samples t-test (for normally distributed variables) and the Mann-
Whitney U test (for non-parametric variables). One-way analysis
of variance (ANOVA) was used where there were more than two
independent groups. Univariate andmultivariate logistic regression
analyses were used to identify variables predictive of critical care
Table 1
Definition of primary aetiology of acute pancreatitis.
Primary Aetiology Definition
Gallstones Diagnosis of gallstones on ultrasound
Alcohol History of recent alcohol excess
Hypertriglyceridaemia Mild, moderate or severe hypertriglyceridaemia with no
gallstones nor alcohol excess
Iatrogenic Acute pancreatitis as a result instrumentation of the
biliary tree or pancreatic duct
Abnormal bile duct Acute pancreatitis caused by periampullary cancer
Idiopathic Absence of gallstones, alcohol excess,
hypertriglyceridaemia, iatrogenic causes and
malignancy
A. Adiamah et al. / Clinical Nutrition ESPEN 39 (2020) 227e233 229admission, LOS, readmission to hospital, and mortality. A p value of
<0.05 was deemed to indicate a statistically significant difference.3. Results
3.1. Study population
In total, 304 patients with a mean ± SD age of 56.1 ± 19.7 years
met the inclusion criteria: 217 (71.4%) patients were in the nor-
motriglyceridaemia group, 47 (15.5%) patients in the mildTable 2






Age, mean (SD), years 57.8 (20.4) 41.2 (23
18e39, n (%) 49 (22.6) 9 (19.2)
40e59, n (%) 62 (28.6) 21 (44.7
60e79, n (%) 63 (29.0) 13 (27.7
80, n (%) 43 (19.8) 4 (8.5)
Gender
Male, n (%) 103 (47.5) 30 (63.8
Female, n (%) 114 (52.5) 17 (36.2
BMI (kg/m2)
<30, n (%) 137 (63.1) 32 (68.1
30, n (%) 74 (34.1) 13 (27.7
Unknown, n (%) 6 (2.8) 2 (4.3)
Smoking status
Smoker, n (%) 39 (18.0) 12 (25.5
Non-smoker, n (%) 174 (80.2) 31 (66.0
Unknown, n (%) 4 (1.8) 4 (8.5)
Severity
APACHE II score < 9 78 (35.9) 20 (44.7
APACHE II score  9 92 (42.4) 15 (31.9
Unknown 47 (21.7) 12 (25.5
Biochemistry
Triglyceride concentration, median (interquartile
range), mmol/L
1 (0.8e1.2) 1.9 (1.8
C-reactive protein concentration, median
(interquartile range), mg/L
21.0 (6.0e122.0) 23.5 (6.
White cell count, mean (SD), x10^9 cells/L 13.2 (5.4) 13.96 (5
APACHE II score, mean (SD) 9.6 (4.6) 8.4 (4.5
Primary aetiology, n (%)
Gallstones 133 (61.3) 19 (40.0
Alcohol 28 (12.9) 14 (30.0
Hypertriglyceridaemia 0 14 (30.0
Iatrogenic: post-ERCP or cholecystectomy 6 (2.8) 0
Abnormal bile duct 4 (1.8) 0
Idiopathic 46 (21.2) 0
Outcome
Duration of stay, median (interquartile range),
days
4 (2.5e7.0) 6 (3.0e
Critical care admission, n (%) 16 (7.4) 8 (17.0)
Hospital readmission, n (%) 23 (10.6) 6 (12.8)
Mortality, n (%) 17 (7.8) 2 (4.3)
* indicates statistically significant differences (p < 0.05).hypertriglyceridaemia group and 40 (13.2%) patients were in the
moderate-to-severe hypertriglyceridaemia group (Table 2). The
mean ± SD age of patients with acute pancreatitis who had
hypertriglyceriademia was significantly lower (mild: 41.2 ± 23.7
years and moderate-to-severe: 48.4 ± 15.0 years) compared with
those in the normotriglyceridaemia group (57.7 ± 20.4 years,
p ¼ 0.027). There was a greater proportion of male patients in the
hypertriglyceriademia groups compared with those in the normo-
triglyceridaemia group (mild: 63.8%, moderate-to-severe: 60.0% vs.
normotriglyceridaemia: 47.5%, p¼ 0.04). The percentage of patients
who were overweight or obese were comparable in all groups
(normotriglyceridaemia: 34.1% vs. mild: 27.7% and moderate-to-
severe: 37.5%, p ¼ 0.577). There was a greater percentage of
smokers in the hypertriglyceriademia groups (mild: 25.5% and
moderate-to-severe: 32.5% vs. normotriglyceridaemia: 18.0%,
p ¼ 0.063).
There was a greater percentage of patients with APACHE II score
of 9 in the normotriglyceridaemia group compared with the
hypertriglyceridaemia groups (p ¼ 0.067). However, 68 patients
(22.4%) had unknown APACHE II scores. Those in the moderate-to-
severe hypertriglyceridaemia group had a greater median CRP
concentration (50.5 mg/L) compared with the mild hyper-
triglyceridaemia and normotriglyceridaemia groups (23.5mg/L and
21.0 mg/L respectively). All groups had high mean ± SD white cellpertriglyceriademia
)
Moderate-to-severe





.7) 48.4 (15.0) 56.07 (19.7) 0.03*
15 (37.5) 73 (24.0)
) 15 (37.5) 98 (32.2)
) 9 (22.5) 85 (28.0)
1 (2.5) 48 (15.8)
0.04*
) 24 (60.0) 157 (51.6)
) 16 (40.0) 147 (48.4)
0.58
) 25 (62.5) 194 (63.8)
) 15 (37.5) 102 (33.6)
0 8 (2.6)
0.06
) 13 (32.5) 64 (21.1)
) 27 (67.5) 232 (76.3)
0 8 (2.6)
) 23 (57.5) 121 (39.8%) 0.07
) 8 (20.0) 115 (37.8%)
) 9 (22.5) 68 (22.4%)
e2.1) 3.65 (2.4e5.9) 1.2 (0.9
e1.8)
<0.01*
0e83.0) 50.5 (19.0e114.0) 24.5 (7.0
e115.0)
0.18
.5) 13.44 (5.6) 13.3 (5.5) 0.35
9) 7.4 (3.05) 9.1 (4.50) 0.07
) 14 (35.0) 166 (54.6) <0.01*
) 12 (30.0) 54 (17.8) <0.01*
) 14 (35.0) 28 (9.2) <0.01*
0 6 (2.0) 0.30
0 4 (1.3) 0.45
0 46 (15.1) 0.04*
11.0) 5 (2.0e10.5) 4 (2.0e8.0) <0.01*
9 (22.5) 33 (10.9) 0.01*
4 (10.0) 33 (10.9) 0.90
4 (10.0) 23 (7.6) 0.58
A. Adiamah et al. / Clinical Nutrition ESPEN 39 (2020) 227e233230counts (normotriglyceridaemia: 13.2 ± 5.4 vs. mild: 14.0 ± 5.5 and
moderate-to-severe: 13.4 ± 5.6  109 cells/L).
3.2. Triglyceride concentrations and hypertriglyceridaemia
The overall median (interquartile range) triglyceride concen-
tration was low at 1.2 mmol/L (0.9e1.8 mmol/L). It was 1.9 mmol/L
(1.8e2.1 mmol/L) in the mild hypertriglyceridaemia group and
3.65 mmol/L (2.4e5.9 mmol/L) in the moderate-to-severe hyper-
triglyceridaemia group.
3.3. Primary aetiology of acute pancreatitis
Gallstones were the most common aetiology of acute pancrea-
titis (55%), followed by alcohol (18%), idiopathic (15%) and hyper-
lipidaemia (9%). Associated aetiologies are described in Table 2.
3.4. Length of stay
Patients with acute pancreatitis and hypertriglyceridaemia
stayed in hospital for a median of 1e2 days longer than those with
normotriglyceridaemia at admission. The median length of stay
when triglycerides were normal were 4 days (interquartile range
2.5e7 days), while patients with mild hypertriglyceridaemia stayed
for 6 days (interquartile range 3e11 days) and those with
moderate-to-severe hypertriglyceridaemia stayed for 5 days
(interquartile range 2e10.5 days), p ¼ 0.0043.
3.5. Admission to critical care (ICU/HDU)
Univariate and multivariate logistic regression analyses were
performed to identify variables that could predict admission to
critical care, mortality and readmission to hospital. The univariate
and multivariate logistic regression analyses for critical care
admission are summarised in Table 3. Based on the univariate lo-
gistic regression; patients with acute pancreatitis and mild hyper-
triglyceridaemia were 2.5 times more likely to be admitted to
critical care: odds ratio (OR) 2.58, 95% Confidence Interval (CI) 1.03
to 6.44, p ¼ 0.043. Patients with moderate-to-severe hyper-
triglyceridaemia and acute pancreatitis were almost four times
more likely to need critical care: OR 3.65, 95% CI 1.48 to 8.97,
p ¼ 0.005. Other significant predictors of critical care admission on
the univariate analysis were presence of gallstones (OR 0.43, 95% CI
0.20 to 0.90, p ¼ 0.026) and CRP concentrations of 120 mg/L (ORTable 3
Logistic regression for critical care admission.
Parameter Category Univ
OR 95% C
Gender Male 0.10 0.03e
Female 1.15 0.56e




Hypertriglyceridaemia No 0.08 0.05e
Mild 2.58 1.03e
Moderate-to-severe 3.65 1.48e
Gallstones No 0.18 0.11e
Yes 0.43 0.20e
CRP, mg/L 0e119 0.07 0.04e
120 1.01 1.00e
APACHE II score 0e9 0.13 0.07e
9 0.98 0.07e
* indicates statistically significant differences (p < 0.05).1.01, 95% CI 1.00 to 1.02, p ¼ 0.0001). In the multivariate logistic
regression analysis, patients with moderate-to-severe hyper-
triglyceridaemia were six times more likely to be admitted to
critical care (OR 5.66, 95% CI 1.87 to 17.19, p ¼ 0.002).
3.6. Mortality
Univariate logistic regression showed that patients aged 80
years or above with acute pancreatitis were eleven times more
likely to die than younger patients (OR 11.83, 95% CI 2.51 to 55.74,
p ¼ 0.002). Patients with acute pancreatitis secondary to bile duct
abnormality in the form of primary or metastatic malignancy were
thirteen times more likely to die in univariate analysis: (OR 13.29,
95% CI 1.78 to 99.11, p ¼ 0.012). However, in both univariate and
multivariate regression analysis, hypertriglyceridaemia was not
predictive of mortality. The univariate and multivariate regression
analyses for mortality are summarised in Table 4.
3.7. Readmission to hospital
The logistic regression analysis for readmission to hospital is
summarised in Table 5. Univariate logistic regression analysis
revealed that female patientswere twice as likely to be readmitted to
hospital following an episode of acute pancreatitis (OR 2.34, 95% CI
1.10 to 5.01, p¼ 0.029). Patients aged 40e59were also more likely to
be readmitted in the univariate analysis (OR 0.32, 95% CI 0.12 to 0.85,
p ¼ 0.022). In the multivariate logistic regression analysis, female
gender (OR2.57, 95%CI 1.13 to 5.81, p¼ 0.024) and age of 40e59years
(OR 0.30, 95% CI: 0.11 to 0.82, p¼ 0.019)were significant predictors of
readmission to hospital. However, the severity of hyper-
triglyceridaemia did not influence the risk of readmission to hospital.
4. Discussion
4.1. Main findings
The main finding this single centre prospective observational
studywas thatmoderate-to-severe hypertriglyceriademia inpatients
with acute pancreatitis was associated with significantly increased
risk of critical care (ICU/HDU) admission. On univariate analysis pa-
tientswith eithermild ormoderate-to-severe hypertriglyceriademia,
irrespective of underlying aetiology of pancreatitis, had an increased
risk of critical care admission, with a 4-fold increased risk in those
with moderate-to-severe disease. The significance of moderate-to-ariate Multivariate
I p value OR 95% CI p value
0.31
2.37 0.70 2.44 0.94e6.29 0.07
0.26
3.18 0.65 0.96 0.31e3.01 0.94
2.64 0.94 0.42 0.09e1.88 0.256
2.15 0.38 0.45 0.06e3.12 0.42
0.13
6.44 0.04* 2.59 0.79e8.55 0.12
8.97 0.01* 5.66 1.87e17.19 <0.01*
0.29
0.90 0.03* 0.704 0.26e1.90 0.49
0.12
1.02 <0.01* 1.00 1.00e1.01 0.04*
0.23
0.23 0.62 1.06 0.92e1.21 0.42
Table 4
Logistic regression for mortality.
Parameter Category Univariate Multivariate
OR 95% CI p value OR 95% CI p value
Gender Male 0.26 0.07e0.93
Female 0.44 0.18e1.10 0.08 0.74 0.25e2.21 0.59
Age (years) 18e39 0.03 0.01e0.11
40e59 1.91 0.36e10.13 0.45 1.03 0.16e6.56 0.98
60e79 1.75 0.31e9.86 0.52 0.45 0.04e4.67 0.50
80 11.83 2.51e55.74 <0.01* 3.71 0.37e36.97 0.26
Hypertriglyceridaemia No 0.09 0.05e0.14 <0.01*
Mild 0.52 0.11e2.34 0.40 0.43 0.05e4.03 0.46
Moderate-Severe 1.31 0.42e4.11 0.65 4.08 0.89e18.58 0.07
Gallstones No 0.10 0.07e0.20
Yes 0.50 0.21e1.19 0.12 0.62 0.18e2.09 0.44
Duct anomaly No 0.08 0.05e0.12
Yes 13.29 1.78e99.11 0.01* 6.27 0.41e96.06 0.19
APACHE II score 0e8 0.05 0.02e0.12
9 1.10 0.99e1.23 0.08 1.00 0.99e1.34 0.07
* indicates statistically significant differences (p < 0.05).
Table 5
Logistic regression for readmission.
Parameter Category Univariate Multivariate
OR 95% CI p value OR 95% CI p value
Gender Male 0.03 0.01e0.12
Female 2.34 1.10e5.01 0.03* 2.57 1.13e5.81 0.02*
Age (years) 18e39 0.24 0.13e0.42
40e59 0.32 0.12e0.85 0.02* 0.30 0.11e0.82 0.02*
60e79 0.50 0.20e1.23 0.13 0.54 0.21e1.38 0.20
80 0.28 0.08e1.04 0.06 0.33 0.09e1.26 0.11
Hypertriglyceridaemia No 0.12 0.08e0.18 <0.01*
Mild 1.23 0.47e3.22 0.67 1.33 0.48e3.67 0.58
Moderate-Severe 0.94 0.31e2.87 0.91 0.83 0.26e2.66 0.75
Gallstones No 0.15 0.09e0.25
Yes 0.65 0.32e1.35 0.25 0.48 0.22e1.05 0.07
* indicates statistically significant differences (p < 0.05).
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sion remained even after mutually adjusting for age, gender, gall-
stones and APACHE II score. Patients with both mild and moderate-
to-severe hypertriglyceridaemia also had a longer median hospital
LOS than those with normotriglyceridaemia (6 vs. 4 days). However,
hypertriglyceridaemia did not influence the risk of readmission or
mortality. Age and biliary structural abnormality were the factors
identified that predicted an increased risk of mortality in this group.
However, as there were only 4 patients with structural biliary ab-
normalities, this must be interpreted with caution.
Demographic data showed that patients with hyper-
triglyceridaemia were significantly younger than those with nor-
motriglyceridaemia and were more likely to be male smokers. The
commonest primary aetiology of acute pancreatitis in our study
was gallstones, followed by alcohol, idiopathic causes, hyper-
triglyceridaemia, iatrogenic causes and structural abnormalities of
the biliary system. Eighteen years after an initial study on acute
pancreatitis in the same geographical region [16], the trends in
aetiology of acute pancreatitis remained consistent; gallstones
continue to be the leading cause of acute pancreatitis (49% in 2001,
55% in 2018). The occurrence of alcohol excess as a primary aeti-
ology of acute pancreatitis increased by 3% from 2001 to 2018,
consistent with the increasing trend of alcohol use disorders.
4.2. What is available in the literature?
Whilst attempts have been made to explore the pathophysi-
ology of hypertriglyceriademia as a primary cause of acutepancreatitis, its role as an epiphenomenon [2] of the condition is
less well understood. In this study hypertriglyceriademia was
present in 33 of 166 patients who had gallstones (19.9%) and 26 of
54 patients with a history of alcohol excess (48.1%). Alcohol excess,
obesity and hereditary disorders have been postulated to lead to
secondary hypertriglyceriademia due to increased concentrations
of chylomicrons and very-low density lipoproteins (VLDL). Obesity
is further thought to exacerbate the severity of acute pancreatitis
via effects on cytokines, adipokines, damage-associated molecular
patterns and unsaturated fatty acid-mediated lipotoxicity [17]. In
the setting of hypertriglyceriademia and another aetiological cause
of acute pancreatitis it is difficult to decipher which is an epiphe-
nomenon and which is the primary precipitant of the condition. It
is, however, more probable that underlying genetic predilection,
metabolic imbalances and environmental factors interact and
contribute to the complexity of hypertriglyceriademia within the
context of acute pancreatitis.
In the present study, patients with hypertriglyceriademia
developed acute pancreatitis at a significantly younger age
compared with the normotriglyceridaemic group, consistent with
the results of a previous study [4]. Our female patients were twice
as likely to be readmitted to hospital after an episode of acute
pancreatitis compared with men, before and after adjusting for age,
serum triglyceride concentrations and presence of gallstones. Few
studies linked gender to outcomes after acute pancreatitis, but it
has been observed that being young and male, with a history of
alcohol excess were risk factors associated with readmissions after
acute pancreatitis [18].
A. Adiamah et al. / Clinical Nutrition ESPEN 39 (2020) 227e233232The association between hypertriglyceridaemia in acute
pancreatitis and critical care admission is consistent with existing
literature. A retrospective observational study of 582 patients with
acute pancreatitis in 2016 found that a serum triglyceride concen-
tration 2.26 mmol/L in acute pancreatitis was an independent
predictor of admission to ICU, and developing local and systemic
complications [5]. Similarly, in a large retrospective study of 1539
patients with acute pancreatitis, hypertriglyceridaemia was associ-
ated with greater severity and poorer prognosis of acute pancrea-
titis, persistent systemic inflammatory response syndrome and
increased ICU admission [6]. Increased need for ICU admission and
an increased overall LOS have also been reported previously [5].
Mortality from acute pancreatitis in our study was 7%, compa-
rable with a local estimate of 7.7% from our previous study [16] and
global estimates of 1e7% [19]. On univariate analysis, octogenarians
were eleven times more likely to die from acute pancreatitis than
any other age group. Univariate and mutually adjusted multivariate
analyses demonstrated that patients with primary chol-
angiocarcinoma or a metastatic biliary lesion causing abnormality
in biliary architecture were at significant risk of dying from acute
pancreatitis. A meta-analysis performed in 2010 found that the risk
of death from acute pancreatitis increased with age, co-morbidities
and severity of disease; mortality was highest among patients with
organ failure and infected necrosis [20].
4.3. Strengths and limitations
Our study comprehensively analysed the occurrence of hyper-
triglyceridaemia both as a primary aetiology of acute pancreatitis,
and as a concurrent phenomenon in other primary aetiologies of
acute pancreatitis. We reinforced current evidence on hyper-
triglyceridaemia and poorer outcomes after acute pancreatitis,
particularly with regards to critical care admission and LOS. We
were able to compare the present primary aetiology of acute
pancreatitis in our geographical region with the primary aetiology
in 2001. Moreover, we also shed light on the association between
hypertriglyceridaemia and developing acute pancreatitis at a
younger age.
However, there are some limitations to our study that need
highlighting. The study population was limited to a single centre;
experience at a large tertiary teaching hospital and the regional
population may not be completely representative. The absence of a
sample size calculation may have caused a lack of power to detect a
difference in hypertriglyceridaemia and the risk of mortality and
risk of readmission. The UK clinical guidelines for the management
of acute pancreatitis recommends an APACHE II score of 9 as an
accurate severity stratification for acute pancreatitis [15]. A signif-
icant proportion of missing data on APACHE II scores of patients
prevented any meaningful interpretation of the APACHE II scores
between patients as a predictor of severity.
There is currently a lack of consensus for the minimum diag-
nostic serum triglyceride concentration to identify hyper-
triglyceridaemia as a primary aetiology of acute pancreatitis. In our
study, hypertriglyceridaemia was diagnosed as the primary aeti-
ology if patients hadmild or moderate hypertriglyceridaemia in the
absence of other causes. However, if a patient had severe hyper-
triglyceriademia, this was defined as the primary cause of acute
pancreatitis regardless of the presence of other potential aetiol-
ogies. While the presence of severe hypertriglyceridaemia
(>11.3 mmol/L, >1000 mg/dL) was considered diagnostic for
hypertriglyceridaemia as the primary aetiology [21], triglyceride
concentrations in our patients were generally low; only a third of
patients had hypertriglyceridaemia. Another study that evaluated
hypertriglyceridaemia in acute pancreatitis similarly found
elevated triglycerides in a third of the included 1233 patients inagreement with our findings, which consisted of 10% with mod-
erate hypertriglyceridaemia and 22% with severe hyper-
triglyceridaemia [14]. As there is no clear threshold at which
hypertriglyceridaemia is known to trigger acute pancreatitis [10],
hypertriglyceridaemia remains a probable primary aetiology of
acute pancreatitis if serum triglyceride concentrations are raised
and other aetiologies of acute pancreatitis are excluded [21].
5. Conclusion
In this study moderate-to-severe hypertriglyceriademia was
predictive of critical care admission and increased LOS. Whilst this
is suggestive of severity associated with hypertriglyceriademia the
lack of an association with mortality is possibly due to a lack of
power to detect this. A larger multicentre study to assess critical
care admission and mortality with adequate power may be needed
in the future to further explore the role of hypertriglyceriademia in
the prognostication of acute pancreatitis.
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